Discontinuation report DOM-CIPROFLOXACIN
| Report ID | 128343 |
| Drug Identification Number | 02251280 |
| Brand name | DOM-CIPROFLOXACIN |
| Common or Proper name | Ciprofloxacin tablets |
| Company Name | DOMINION PHARMACAL |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CIPROFLOXACIN |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | J01MA |
| ATC description | QUINOLONE ANTIBACTERIALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2017-12-31 |
| Remaining supply date | 2017-12-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111, AVENUE ROYALMOUNT MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2020-11-13 | French | Compare |
| v1 | 2020-11-13 | English | Compare |
Showing 1 to 2 of 2